Hypersensitivity reactions to vaccine constituents: A case series and review of the literature

Dermatitis

Volumn 23, Issue 3, 2012, Pages 102-109

  Leventhal, Jonathan S ^a   Berger, Emily M ^a   Brauer, Jeremy A ^a   Cohen, David E ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 PHENOXYETHANOL; ALUMINUM; ANTIHISTAMINIC AGENT; DIPHTHERIA PERTUSSIS TETANUS VACCINE; DRUG PRESERVATIVE; FORMALDEHYDE; GELATIN; INFLUENZA VACCINE; NEOMYCIN; OVALBUMIN; PREDNISONE; THIOMERSAL;

ARTICLE; BLISTER; CASE REPORT; CHILD; CLINICAL EVALUATION; DELAYED HYPERSENSITIVITY; DIPHTHERIA; FEMALE; FOOD AND DRUG ADMINISTRATION; HAY FEVER; HUMAN; INFLUENZA; INFLUENZA VACCINATION; INJECTION SITE EDEMA; INJECTION SITE ERYTHEMA; INJECTION SITE REACTION; INJECTION SITE SWELLING; MALE; MEDICAL LITERATURE; PATCH TEST; PERTUSSIS; PRESCHOOL CHILD; PRIORITY JOURNAL; PRURITUS; SCHOOL CHILD; SKIN MANIFESTATION; TETANUS; VON WILLEBRAND DISEASE;

ADJUVANTS, PHARMACEUTIC; ADVERSE DRUG REACTION REPORTING SYSTEMS; ALUMINUM; CHILD; CHILD, PRESCHOOL; DRUG HYPERSENSITIVITY; FEMALE; HUMANS; HYPERSENSITIVITY, DELAYED; MALE; RISK FACTORS; VACCINES;

EID: 84865136559     PISSN: 17103568     EISSN: None     Source Type: Journal    
DOI: 10.1097/DER.0b013e31825228cf     Document Type: Article

References (48)

1. Wood RA, Berger M, Dreskin SC, et al. An algorithm for treatment of patients with hypersensitivity reactions after vaccines. Pediatrics 2008;122: 771Y777.
2. Heirdary N, Cohen DE. Hypersensitivity reactions to vaccine components. Dermatitis 2005;16:115Y120.
3. Madaan A, Maddox DE. Vaccine allergy: diagnosis and management. Immunol Allergy Clin North Am 2003;23:555Y588. (Pubitemid 38030159)
4. Fritsche PJ, Helbling A, Ballmer-Weber BK. Vaccine hypersensitivityV update and overview. Swiss Med Wkly 2010;140:238Y246.
5. Tariq SM, Matthews SM, Hakim EA, et al. Egg allergy in infancy predicts respiratory allergic disease by 4 years of age. Pediatr Allergy Immunol 2000;11:162Y167. (Pubitemid 30666556)
6. Zeiger RS. Current issues with influenza vaccination in egg allergy. J Allergy Clin Immunol 2002;110:834Y840. (Pubitemid 36005868)
7. James JM, Burks AW, Roberson PK, et al. Safe administration of the measles vaccine to children allergic to eggs. N Engl JMed 1995;332:1262Y1266.
8. James JM, Zeiger RS, Lester MR, et al. Safe administration of influenza vaccine to patients with egg allergy. J Pediatr 1998;133:624Y628. (Pubitemid 28521210)
9. Gagnon R, Primeau MN, Des Roches A, et al. Safe vaccination of patients with egg allergy with an adjuvanted pandemic H1N1 vaccine. J Allergy Clin Immunol 2010;126:317Y323.
10. Aukrust L, Almeland TL, Refsum D, et al. Severe hypersensitivity or intolerance reactions to measles vaccine in six children. Clinical and immunological studies. Allergy 1980;35:581Y587. (Pubitemid 10019045)
11. Herman JJ, Radin R, Schneiderman R. Allergic reactions to measles (rubeola) vaccine in patients hypersensitive to egg protein. J Pediatr 1983;102: 196Y199. (Pubitemid 13194697)
12. Bierman CW, Shapiro GG, Pierson WE, et al. Safety of influenza vaccination in allergic children. J Infect Dis 1977;136:S652YS655. (Pubitemid 8286942)
13. Patja A, Makinen-Kiljunen S, Davidkin I, et al. Allergic reactions to measles-mumps-rubella vaccination. Pediatrics 2001;107:e27.
14. Sakaguchi M, Inouye S. Systemic allergic reactions to gelatin included in vaccines as a stabilizer. Jpn J Infect Dis 2000;53:189Y195. (Pubitemid 32140741)
15. Singer S, Johnson CE, Mohr R, et al. Urticaria following varicella vaccine associated with gelatin allergy. Vaccine 1999;17:327Y329. (Pubitemid 28557179)
16. Kelso JM, Jones RT, Yunginger JW. Anaphylaxis to measles, mumps, and rubella vaccine mediated by IgE to gelatin. J Allergy Clin Immunol 1993;91: 867Y872. (Pubitemid 23118503)
17. Zent O, Hennig R. Post-marketing surveillance of immediate allergic reactions: polygeline-based versus polygeline-free pediatric TBE vaccine. Vaccine 2004;23:579Y584. (Pubitemid 39473186)
18. Pool V, Braun MM, Kelso JM, et al. US Vaccine Adverse Event Reporting System. Prevalence of anti-gelatin IgE antibodies in people with anaphylaxis after measles-mumps rubella vaccine in the United States. Pediatrics 2002;110:e71.
19. Taniguchi K, Fujisawa T, Ihara T, et al. Gelatin-induced T-cell activation in children with nonanaphylactic-type reactions to vaccines containing gelatin. J Allergy Clin Immunol 1998;102:1028Y1032. (Pubitemid 29018321)
20. Lindblad EB. Aluminum compounds for use in vaccines. Immunol Cell Biol 2004;82:497Y505.
21. Fischer T, Rystedt I. A case of contact sensitivity to aluminum. Contact Dermatitis 1982;8:343.
22. Tosti A, Melino M, Bardazzi F. Systemic reactions due to thimerosal. Contact Dermatitis 1986;15:187Y188.
23. Eickhoff TC, Myers M. Conference report: aluminum in vaccines. Vaccine 2002;20:S1YS4.
24. Frost L, Johansen P, Pederson S, et al. Persistent subcutaneous nodules in children hyposensitized with aluminum-containing allergen extracts. Allergy 1985;40:368Y372. (Pubitemid 15042355)
25. Cox NH, Moss C, Forsyth A. Allergy to non-toxoid constituents of vaccines and implications for patch testing. Contact Dermatitis 1988;18: 143Y146. (Pubitemid 18077540)
26. Bergfors E, Bjorkelund C, Trollfors B. Nineteen cases of persistent pruritic nodules and contact allergy to aluminum after injection of commonly used aluminum-adsorbed vaccines. Eur J Pediatr 2005;164:691Y697. (Pubitemid 41476495)
27. Garcia-Patos V, Pujol RM, Alomar A, et al. Persistent subcutaneous nodules in patients hyposensitized with aluminum-containing allergen extracts. Arch Dermatol 1995;131:1421Y1424.
28. Veien NK, Hattel T, Justesen O, et al. Aluminum allergy. Contact Dermatitis 1986;15:295Y297.
29. Marsee DK, Williams JM, Velazquez EF. Aluminum granuloma after administration of the quadrivalent human papillomavirus vaccine. Report of a case. Am J Dermatopathol 2008;30:622Y624.
30. Breithaupt A, Jacob SE. Thimerosal and the relevance of patch-test reactions in children. Dermatitis 2008;19:275Y277.
31. Offit PA, Jew RK. Addressing parents' concerns: do vaccines contain harmful preservatives, adjuvants, additives, or residuals? Pediatrics 2003;112: 1394Y1397.
32. Marks JG, Belsito DV, DeLeo VA, et al. North American Contact Dermatitis Group patch-test results, 1998Y2000. Am J Contact Dermat 2003; 14:59Y62. (Pubitemid 36988512)
33. Bruckner AL, Weston WL, Morelli JG. Does sensitization to contact allergens begin in infancy? Pediatrics 2000;105:e3.
34. Ockenfels HM, Seemann U, Goos M. Contact allergy in patients with periorbital eczema: an analysis of allergens. Dermatology 1997;195:119Y124.
35. Maibach H. Acute laryngeal obstruction presumed secondary to thimerosal (merthiolate) delayed hypersensitivity. Contact Dermatitis 1975;1: 221Y222.
36. Lee-Wong M, Resnick D, Chong K. A generalized reaction to thimerosal from an influenza vaccine. Ann Allergy Asthma Immunol 2005;94:90Y94. (Pubitemid 40129642)
37. Zheng W, Dreskin SC. Thimerosal in influenza vaccine: an immediate hypersensitivity reaction. Ann Allergy Asthma Immunol 2007;99:574Y575. (Pubitemid 350308761)
38. Karincaoglu Y, Aki T, Erguvan-Onal R, et al. Erythema multiforme due to diphtheria-pertussis-tetanus vaccine. Pediatr Dermatol 2007;24:334Y335. (Pubitemid 46848973)
39. Audicana MT, Munoz D, del Pozo MD, et al. Allergic contact dermatitis from mercury antiseptics and derivatives: study protocol of tolerance to intramuscular injections of thimerosal. Am J Contact Dermat 2002;13:3Y9. (Pubitemid 34205622)
40. Fitzgerald KA, Davis A, Russell AD. Mechanism of action of chlorhexidine diacetate and phenoxyethanol singly and in combination against gramnegative bacteria. Microbios 1992;70:215Y230.
41. De Groot AC, Van Ginkel CJ, Weijland JW. Methyldibromoglutaronitrile (Euxyl K 400): an important "new" allergen in cosmetics. J Am Acad Dermatol 1996;35:743Y747. (Pubitemid 26389474)
42. Sasseville D. Hypersensitivity to preservatives. Dermatol Ther 2004;17: 251Y263. (Pubitemid 38823473)
43. Vogt T, Landthaler M, StolzW. Generalized eczema in an 18-month-old boy due to phenoxyethanol in DPT vaccine. Contact Dermatitis 1998;38:50Y51. (Pubitemid 28059746)
44. Ring J. Exacerbation of eczema by formalin-containing hepatitis B vaccine in formaldehyde-allergic patient. Lancet 1986;2:522Y523. (Pubitemid 16049549)
45. Kwittken PL, Rosen S, Sweinberg SK. MMRvaccine and neomycin allergy. Am J Dis Child 1993;147:128Y129.
46. Crockett RE, Lockey RF. Vaccine hypersensitivity. Immunol Allergy Clin North Am 2001;21:707Y743. (Pubitemid 33131240)
47. Watson JC, Peter G. General immunization practices. In: Plotkin SA, Orenstein WA, eds. Vaccines. 3rd ed. Philadelphia, PA: WB Saunders Co; 1999:47Y73.
48. Allergen Patch Test. T.R.U.E. Test\ Product Information. Available at: http://www.truetest.com/PhysicianPDF/HCP8-TT-Rx-info.pdf. Accessed February 13, 2012.